Keyphrases
Respiratory Syncytial Virus Infection
100%
Human Respiratory Syncytial Virus (hRSV)
100%
Pharmacological Treatment
100%
High-risk Infants
100%
High-risk Population
40%
Comorbidity
20%
Area Cover
20%
Monoclonal Antibody
20%
New Therapies
20%
New Targets
20%
Older Adults
20%
Virus Discovery
20%
Health Systems
20%
F Protein
20%
Respiratory Infection
20%
Expert Opinion
20%
Infections in children
20%
Population at Risk
20%
Older Patients
20%
Hospitalization Rate
20%
Bibliographical Review
20%
Nanobody
20%
Antiviral Molecules
20%
Pharmacology, Toxicology and Pharmaceutical Science
Human Respiratory Syncytial Virus
100%
Respiratory Syncytial Virus Infection
100%
Comorbidity
33%
Monoclonal Antibody
33%
Clinical Study
33%
Respiratory Tract Infection
33%
Antivirus Agent
33%
Nanobody
33%